Références
- 1
Fraunfelder F W.
Drug-induced ocular inflammatory diseases.
Drugs Today.
2007;
43 (2)
117-123
- 2
Vaudaux J D, Guex-Crosier Y.
Rifabutin-induced cystoid macular oedema.
J Antimicrob Chemother.
2002;
49 (2)
421-422
- 3
Miller M, Phillips P, Toma E.
Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol.
MAC Study Group of the Canadian HIV Trials Network.
N Engl J Med.
1994;
330 (6)
438-439
- 4
Moorphy R S, Valluri S, Jampol L M.
Drug-induced uveitis.
Surv Ophthalmol.
1999;
43 (5)
466-468
- 5 Vaudaux J D, Guex-Crosier Y. Uvéites médicamenteuses in Brezin AP, Les uvéites –
Rapport SFO 2010. chapitre 45. Masson: Elsevier; 535-547
- 6
Viet Tran H, Ravinet E, Schnyder C et al.
Blood-brain barrier disruption associated with topiramate-induced angle-closure glaucoma
of acute onset.
Klin Monbl Augenheilkd.
2006;
223 (5)
425-427
Yan Guex-Crosier, MD, FEBO
Head of uveitis clinic, Jules Gonin Eye Hospital, University of Lausanne
15 Av. de France
1004 Lausanne
Switzerland
Phone: ++ 41/21/6 26 85 95
Fax: ++ 41/21/6 26 81 22
Email: yan.guex@fa2.ch
